Congress

Implicaciones del uso de la mediana o la media del número de ciclos cuando se estima el coste del tratamiento para el cáncer de próstata resistente a castración metastásico (CPRCm).

Authors: Gozalbo I, Paz S, Lizán L, Granell M

Year: 2016

Congress: XXXVI Jornadas de Economía de la Salud (AES)


Download PDF
Subscribe to Outcomes´10
Todos los campos marcados con un * son obligatorios
Responsible for the data: Outcomes'10, s.l.u., Purpose: Sending commercial communications. Legitimation: Art. 6.1 Consent of the interested party. Recipient: No data is transferred unless expressly authorised. You may exercise your rights on data protection (access, rectification, opposition, deletion, automated decisions, limitation of treatment, portability) by email at dpo@outcomes10.com. In any case, you can request the protection of the Spanish Data Protection Agency through its website www.aepd.es/. In addition, you can consult more information on the privacy policy
Logo
Aenor gestión de calidad
Aenor seguridad e información
Logotipo
Skip to content